Skip to main content

Overactive Bladder News (Page 2)

Related terms: Bladder Hyperactivity, Chronic overactivity of the bladder, Detrusor hyperreflexia, Detrusor instability, Incontinence, Urge, Irritable Bladder, Spasmodic Bladder, Unstable Bladder, Urge Incontinence, Urinary Frequency, OAB, Bladder Muscle Dysfunction - Overactive, bladder dysfunction

Pelvic Floor Muscle Training No Better Than Bladder Training for Overactive Bladder

MONDAY, Oct. 2, 2023 – For women with overactive bladder symptoms, supervised pelvic floor muscle training (PFMT) does not provide additional improvement over bladder training, according to a study...

Urinary Biomarkers Can Differentiate IC/BPS From Other LUTDs

WEDNESDAY, Sept. 6, 2023 – Urinary biomarkers can differentiate interstitial cystitis/bladder pain syndrome (IC/BPS) from other lower urinary-tract dysfunctions (LUTDs) in male patients, according...

Overactive Bladder Symptoms Common With Pelvic Organ Prolapse

TUESDAY, Sept. 5, 2023 – Seven in 10 women with pelvic organ prolapse (POP) report overactive bladder (OAB) symptoms, according to a study published online July 13 in the International Journal of...

FDA Approves Gemtesa (vibegron) Tablets for the Treatment of Patients with Overactive Bladder (OAB)

IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dec. 23, 2020-- Urovant Sciences (Nasdaq: UROV) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug...

FDA Approves Supplemental New Drug Application for Myrbetriq (mirabegron) for Use in Combination with Solifenacin Succinate for the Treatment of Overactive Bladder Symptoms

TOKYO, May 7, 2018 /PRNewswire/ – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food and Drug Administration (FDA) has approved...

FDA Approves Over-the-Counter Oxytrol for Women to treat Overactive Bladder

January, 25, 2013 – The U.S. Food and Drug Administration today approved Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women ages 18 years and older. Oxytrol...

FDA Approves Botox to Treat Overactive Bladder

January 18, 2013 – The U.S. Food and Drug Administration today expanded the approved use of Botox (onabotulinumtoxinA) to treat adults with overactive bladder who cannot use or do not adequately...

FDA Approves Myrbetriq for Overactive Bladder

June 28, 2012 - The U.S. Food and Drug Administration today approved Myrbetriq (mirabegron) to treat adults with overactive bladder, a condition in which the bladder muscle cannot be controlled,...

Anturol Approved by FDA for the Treatment of Overactive Bladder

PARSIPPANY, N.J. and EWING, N.J., Dec. 8, 2011 /PRNewswire/ – Watson Pharmaceuticals, Inc. and Antares Pharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

Botox, estradiol, oxybutynin, Gemtesa